Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1998 Jul;88(7):1015–1016. doi: 10.2105/ajph.88.7.1015

What it takes to control tuberculosis.

C R Horsburgh Jr
PMCID: PMC1508283  PMID: 9663144

Full text

PDF
1015

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. F., Yang Z., Preston-Martin S., Pogoda J. M., Jones B. E., Otaya M., Eisenach K. D., Knowles L., Harvey S., Cave M. D. Patterns of tuberculosis transmission in Central Los Angeles. JAMA. 1997 Oct 8;278(14):1159–1163. [PubMed] [Google Scholar]
  2. Bayer R., Stayton C., Desvarieux M., Healton C., Landesman S., Tsai W. Y. Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary? Am J Public Health. 1998 Jul;88(7):1052–1058. doi: 10.2105/ajph.88.7.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blumberg H. M., Watkins D. L., Berschling J. D., Antle A., Moore P., White N., Hunter M., Green B., Ray S. M., McGowan J. E., Jr Preventing the nosocomial transmission of tuberculosis. Ann Intern Med. 1995 May 1;122(9):658–663. doi: 10.7326/0003-4819-122-9-199505010-00003. [DOI] [PubMed] [Google Scholar]
  4. Comstock G. W. Tuberculosis: is the past once again prologue? Am J Public Health. 1994 Nov;84(11):1729–1731. doi: 10.2105/ajph.84.11.1729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  6. Frieden T. R., Fujiwara P. I., Washko R. M., Hamburg M. A. Tuberculosis in New York City--turning the tide. N Engl J Med. 1995 Jul 27;333(4):229–233. doi: 10.1056/NEJM199507273330406. [DOI] [PubMed] [Google Scholar]
  7. Gordin F. M., Matts J. P., Miller C., Brown L. S., Hafner R., John S. L., Klein M., Vaughn A., Besch C. L., Perez G. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med. 1997 Jul 31;337(5):315–320. doi: 10.1056/NEJM199707313370505. [DOI] [PubMed] [Google Scholar]
  8. Grange J. M., Zumla A. Making DOTS succeed. Directly Observed Treatment, Short Course. Lancet. 1997 Jul 19;350(9072):157–157. doi: 10.1016/s0140-6736(05)62344-6. [DOI] [PubMed] [Google Scholar]
  9. Hanson M. L., Comstock G. W., Haley C. E. Community isoniazid prophylaxis program in an underdeveloped area of Alaska. Public Health Rep. 1967 Dec;82(12):1045–1056. [PMC free article] [PubMed] [Google Scholar]
  10. Lerner B. H. New York City's tuberculosis control efforts: the historical limitations of the "war on consumption". Am J Public Health. 1993 May;83(5):758–766. doi: 10.2105/ajph.83.5.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Liu Z., Shilkret K. L., Tranotti J., Freund C. G., Finelli L. Distinct trends in tuberculosis morbidity among foreign-born and US-born persons in New Jersey, 1986 through 1995. Am J Public Health. 1998 Jul;88(7):1064–1067. doi: 10.2105/ajph.88.7.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGowan J. E., Jr Nosocomial tuberculosis: new progress in control and prevention. Clin Infect Dis. 1995 Sep;21(3):489–505. doi: 10.1093/clinids/21.3.489. [DOI] [PubMed] [Google Scholar]
  13. McKenna M. T., McCray E., Jones J. L., Onorato I. M., Castro K. G. The fall after the rise: Tuberculosis in the United States, 1991 through 1994. Am J Public Health. 1998 Jul;88(7):1059–1063. doi: 10.2105/ajph.88.7.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McKenna M. T., McCray E., Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med. 1995 Apr 20;332(16):1071–1076. doi: 10.1056/NEJM199504203321606. [DOI] [PubMed] [Google Scholar]
  15. Moore M., Onorato I. M., McCray E., Castro K. G. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA. 1997 Sep 10;278(10):833–837. [PubMed] [Google Scholar]
  16. Moore R. D., Chaulk C. P., Griffiths R., Cavalcante S., Chaisson R. E. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1013–1019. doi: 10.1164/ajrccm.154.4.8887600. [DOI] [PubMed] [Google Scholar]
  17. Tabet S. R., Goldbaum G. M., Hooton T. M., Eisenach K. D., Cave M. D., Nolan C. M. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis. 1994 Jan;169(1):189–192. doi: 10.1093/infdis/169.1.189. [DOI] [PubMed] [Google Scholar]
  18. Weis S. E., Slocum P. C., Blais F. X., King B., Nunn M., Matney G. B., Gomez E., Foresman B. H. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994 Apr 28;330(17):1179–1184. doi: 10.1056/NEJM199404283301702. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES